10.17.25 -- Keep Pace With The Next Wave Of Genetic Therapies

This Abzena webinar explores how next-generation cell line platforms streamline biologic development. Experts from Abzena, Revvity, and ProteoNic discuss flexible CLD strategies, integrated analytics, and technologies like AbZelectPRO™ and CHOSOURCE™ to boost productivity, achieve high-quality titers, reduce timelines, and de-risk scale-up, helping developers efficiently bring therapeutic antibodies and difficult-to-express proteins to the clinic. Click here to learn more.

Explore the implications of the newly enacted "One Big Beautiful Bill" and how it will alleviate the administrative burdens faced by clinical research stakeholders and benefit low-income patients.

To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.

In a landscape where health equity and patient-centered research are imperatives, a Patient Experience Organization (PXO) offers a scalable system to ensure every patient understands, engages, and stays.

Selecting the right functional service provider (FSP) for safety services is fundamental to protecting patients and requires a resilient, strategic partnership that enhances trial integrity and outcomes.

Learn how to create a system based on connectivity and automation, aggregated and usable data, flexible analysis, and methods of collaborative data review by centralizing analysis and communications.